TALE-VP64 targeting 14-bp DNA sequence in the promoter of FXN was created, and it increased FXN mRNA levels by 2- to 3-fold in 293FT cells [90] and by 2-fold in human fibroblasts derived from human Friedreich’s ataxia patients [91]. The gene discussed is FXN; the disease is Friedreich ataxia.